University of Calgary

$1.7 million grant awarded to Faculty of Medicine researcher to fight bioterrorism

By Jordanna Heller
Posted July 10, 2008

Watch a video clip online...

Calgary, Alberta, July 10, 2008: Donald Woods, PhD, uses the fraction collector machine to purify proteins for vaccines at his lab.: Digital image by Laurie WangDonald Woods, PhD, uses the fraction collector machine to purify proteins for vaccines at his lab.: Digital image by Laurie WangThe National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health (NIH) has awarded Donald Woods, PhD, of the Faculty of Medicine, University of Calgary, $1.7 million for research into vaccines against agents of bioterrorism.

Woods, who is part of the Calvin, Phoebe and Joan Snyder Institute of Infection, Immunity and Inflammation, is studying and testing vaccine preparations for the prevention of glanders and melioidosis. Glanders is a widespread bacterial disease primarily found in horses that can be transmitted to humans. It has a history of use in biological warfare. Melioidosis, which affects people in Southeast Asia, is also caused by a bacterial agent. The disease can result in pneumonia, septicemia, and if left untreated can become chronic.

The bacteria that cause these diseases are on the U.S. Centers for Disease Control and Prevention's (CDC) category B list of potential bioterrorism agents. Glanders is caused by B. mallei, melioidosis is caused by the closely related organism, B. pseudomallei.   These diseases are considered to be emerging infectious diseases worldwide, and have a high death rate.

"It is important to develop a vaccine against both of these organisms because they are very difficult to treat with antibiotics and even with appropriate antibiotic treatment, mortality is still high, "says Donald Woods.

The microbes Woods studies are potentially dangerous, so he conducts his work in a biosafety level three containment laboratory. That means every time scientists go into the lab they must take special safety and security precautions to protect laboratory personnel and the public against exposure to these agents.

Woods is working in collaboration with investigators at the U.S. Army Medical Research Institute for Infectious Diseases, the University of Georgia, the University of Toledo Health Sciences Center, Cangene Corporation and the Faculty of Veterinary Medicine, University of Calgary.

Donald Woods, PhD, is the Canada Research Chair in Microbiology, receiving funding support from the Canadian Institutes of Health (CIHR) and a Fellow of the Canadian Academy of Health Sciences.

Download a copy of the news release in PDF format. 

About the Faculty of Medicine at the University of Calgary

The U of C's Faculty of Medicine is a national leader in health research with an international reputation for excellence and innovation in health care research, education and delivery. Through its educational programs, the Faculty of Medicine trains the physicians and scientists who will lead the next generation of health practitioners. Through its clinical work, continuing medical education programs, and close relationship with the Calgary Health Region, the Faculty of Medicine moves new treatments and diagnostic techniques from the laboratory bench to the hospital bedside efficiently and effectively, improving patient care.

If you like this story and think others should read about it--why not spread the word!? Use the links below to let others know!

Digg it! | Reddit.com | del.icio.us | facebook

Post new comment

The content of this field is kept private and will not be shown publicly.
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.